{"organizations": [], "uuid": "8b5375c7c0000347f63c8847d38048a6938139f0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-rovi-sees-2018-operating-revenue-g/brief-rovi-sees-2018-operating-revenue-growth-at-mid-single-digit-rate-idUSFWN1QA095", "country": "US", "domain_rank": 408, "title": "BRIEF-Rovi Sees 2018 Operating Revenue Growth At Mid-Single-Digit Rate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-02-20T15:38:00.000+02:00", "replies_count": 0, "uuid": "8b5375c7c0000347f63c8847d38048a6938139f0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-rovi-sees-2018-operating-revenue-g/brief-rovi-sees-2018-operating-revenue-growth-at-mid-single-digit-rate-idUSFWN1QA095", "ord_in_thread": 0, "title": "BRIEF-Rovi Sees 2018 Operating Revenue Growth At Mid-Single-Digit Rate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "laboratorios farmaceuticos rovi sa", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Laboratorios Farmaceuticos ROVI SA (ROVI) :\n* FOR 2018 SEES A MID-SINGLE-DIGIT GROWTH RATE FOR OPERATING REVENUE WITH A RANGE OF 20 MILLION EURO - 30 MILLION EURO SALES OF ENOXAPARIN BIOSIMILAR‍​\n* TO PROPOSE A DIVIDEND OF 0.1207 EUROS PER SHARE FOR FY 2017\n* FY EBITDA DOWN 22 PERCENT AT 30.5 MILLION EUROS VERSUS 39.3 MILLION EUROS YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-20T15:38:00.000+02:00", "crawled": "2018-02-21T21:15:40.018+02:00", "highlightTitle": ""}